Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction

Journal of Thrombosis and Thrombolysis

Volumn 20, Issue 3, 2005, Pages 155-161

  Szabo, Sebastian ^a   Etzel, Diana ^b   Ehlers, Raila ^b   Walter, Thomas ^b   Kazmaier, Silke ^b   Helber, Uwe ^b   Hoffmeister, Hans Martin ^a  

^a Pathologisches Institut   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Abciximab; Myocardial infarction; Platelet leukocyte interactions; Thrombolysis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CD40 ANTIGEN; CD40 LIGAND; CELL MARKER; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; HEPARIN; PADGEM PROTEIN; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MALE; MONOCYTE; MULTIVARIATE ANALYSIS OF VARIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION;

AGED; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; NEUTROPHILS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOLYTIC THERAPY;

EID: 27944489616     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-3546-0     Document Type: Article

References (29)

1. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo. after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142-150. 3275505
2. Hoffmeister HM, Szabo S, Kastner C, et al. Thrombolytic therapy in acute myocardial infarction: Comparison of procoagulant effects of streptokinase and alteplase regimen with focus on the kallikrein system and plasmin. Circulation. 1998;98:2527-2533. 9843458
3. Szabo S, Letsch R, Ehlers R, et al. Absence of paradoxical thrombin activation by fibrin- specific thrombolytics in acute myocardial infarction. Comparison of single bolus tenecteplase and front-loaded alteplase. Thromb Res. 2002;106:113-119. 10.1016/S0049-3848(02)00084-1
4. Bazzoni G, Dejana E, Del Maschio A. Platelet-neutrophil interactions: Possible relevance in thepathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491-499. 1820986
5. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851. 10.1038/359848a0
6. Ruf A, Schlenk RF, Maras A, Morgenstern E, Patscheke H. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood. 1992;80:1238-1246. 1355374
7. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost. 1993;70:514-521. 7505065
8. Ruf A, Patscheke H. Platelet-induced neutrophil activation: Platelet-expressed fibrinogen induced the oxidative burst in neutrophils by an interaction with CD11c/CD18. Br J Haematol. 1995;90:791-796. 7669656
9. Boukerche H, Ruchaud-Sparagano MH, Rouen C, Brochier J, Kaplan C, McGregor JL. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD 62P) inhibits ristocetin-induced platelet aggregation. Br J Haematol. 1996;92:442-451. 10.1046/j.1365-2141.1996.d01-1485.x
10. Topol EJ, Califf RM, Van de Werf F, Willerson JT and the GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy of combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. The Lancet. 2001;357:1905-1910. 10.1016/S0140-6736(00)05059-5
11. Moliterno DJ, Califf RM, Aguirre FV, et al., for the EPIC Study Investigators. Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (The EPIC Trial). Am J Cardiol. 1995;75:559-562. 10.1016/S0002-9149(99)80616-X
12. Stenberg PE, McEver RP, Shuman MA et al. A platelet alpha granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886. 10.1083/jcb.101.3.880
13. Fox JE. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinol. 1994;5:291-304.
14. Serebruany VL, Gurbel PA. Assessment of platelet activity by measuring platelet derived substances in plasma from patients with acute myocardial infarction: Surprising lessons from the GUSTO-III platelet study. Thromb Res. 1999;93:149-150. 10.1016/S0049-3848(98)00176-5
15. Lip GYH, Lydakis C, Nuttall SL et al. A pilot study of streptokinase-induced endothelial injury and platelet activation following myocardial infaction. J Int Med. 2000;248:316-318. 10.1046/ j.1365-2796.2000.00738.x
16. Mascelli MA, Worley S, Veriabo NJ, et al. Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy. Circulation. 1997;96:3860-3866. 9403608
17. Peerschke EIB, Reid KBM, Ghebrehiwet B. Platelet activation by C1q results in the induction of alphaIIb/beta3 integrins (GPIIb/IIIa) and the expression of P-Selectin and procoagulant activity. J Exp Med. 1993;178:579-587. 10.1084/jem.178.2.579
18. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420-1426. 10.1016/S0735-1097(99)00350-2
19. May AE, Neumann FJ, Gawaz M, Ott I, Walter H, Schömig A. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur Heart J. 1997;18:1913-1920. 9447319
20. Fan ST, Edgington TS. Coupling of the adhesive receptor CD 11b/18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 1991;87:50-57. 1670636
21. Altieri DC, Morrissey JH, Edgington TS. Adehesive receptor MAC-1 coordinates the activation of factor X on stimulated cells of monocyte and myeloid differentiation: An alternative initiation of the coagulation protease cascades. Proc Natl Acad Sci USA. 1988;85:7462. 2971972
22. Meisel SR, Shapiro H, Radnay J, et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: Possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol. 1998;31:120-125. 10.1016/ S0735-1097(97)00424-5
23. Furie B, Furie BC. Leukocyte crosstalk at the vascular wall. Thromb Haemost. 1997;78:306-309. 9198171
24. Lopez JA, Dong JF, Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol. 1997;4:323-329. 9288465
25. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogenity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. Am Heart J. 1998;136:398-405. 9736129
26. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on glycoprotein Ib-von Willebrand factor interactions. Blood. 1985;65:32-40. 3155489
27. Szabo S, Etzel D, Ehlers R, et al. Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis. Drugs Exptl Clin Res. 2004;XXX:47-54.
28. Mach F, Schonbeck U, Sukhova GK et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signalling in atherosclerosis. Proc Natl Acad Sci USA. 1997;94:1931-1936. 10.1073/ pnas.94.5.1931
29. Heeschen C, Dimmeler S, Hamm CW; CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104-1111. 10.1056/NEJMoa022600